Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12532828 | 0.98 | LMNA (0.72) | LMNAPOLBNAAAALDH1A1MGLL | |
| SCHEMBL8391467 | 0.96 | LMNA (0.70) | LMNAPOLBNAAAALDH1A1LPAR1 | |
| SCHEMBL4570313 | 0.94 | LMNA (0.72) | LMNAPOLBNAAAALDH1A1SMN1; SMN2 | |
| SCHEMBL28759260 | 0.92 | LMNA (0.77) | LMNAPOLBNAAAALDH1A1MGLL | |
| SCHEMBL8894865 | 0.91 | LMNA (0.59) | LMNAPOLBNAAAALDH1A1MGLL | |
| SCHEMBL8893390 | 0.89 | LMNA (0.57) | LMNAPOLBNAAAALDH1A1LPAR1 | |
| SCHEMBL8895320 | 0.89 | LMNA (0.62) | LMNAPOLBNAAAALDH1A1MGLL | |
| SCHEMBL8893481 | 0.89 | LMNA (0.62) | LMNAPOLBNAAAALDH1A1MGLL | |
| SCHEMBL8893464 | 0.89 | LMNA (0.57) | LMNAPOLBNAAAALDH1A1LPAR1 | |
| SCHEMBL1291727 | 0.89 | NAAA (0.60) | LMNANAAALPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492316-B1 | Production method and production device of high-purity 1,6-hexanediol | Zhejiang Boju New Materials Co., Ltd. | 2022-11-08 | — | — | US | disclosed |
| CN-113683483-B | Production method and device of high-purity 1, 6-hexanediol | 浙江博聚新材料有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-113683483-A | Production method and device of high-purity 1, 6-hexanediol | 浙江博聚新材料有限公司 | 2021-11-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492316-B1 | Production method and production device of high-purity 1,6-hexanediol | ADIPOR1, ADH1C, ADIPOR2 | LMNA 2467/4885POLB 4406/4885NAAA 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.